Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
12.03
16.42
136.49%
Share Warrants & Outstandings
Total Reserve
107.51
13.09
94.42
721.31%
Shareholder's Funds
138.48
25.13
113.35
451.05%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
6.00
-4.01
-66.83%
Secured Loans
1.99
6.00
-4.01
-66.83%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.92
-5.11
6.03
118.00%
Other Long Term Liabilities
0.00
1.28
-1.28
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
5.17
-5.17
-100.00%
Total Non-Current Liabilities
2.91
7.35
-4.44
-60.41%
Current Liabilities
Trade Payables
102.54
5.23
97.31
1,860.61%
Other Current Liabilities
11.07
26.62
-15.55
-58.41%
Short Term Borrowings
32.87
48.11
-15.24
-31.68%
Short Term Provisions
2.73
1.34
1.39
103.73%
Total Current Liabilities
149.21
81.31
67.90
83.51%
Total Liabilities
290.59
113.78
176.81
155.40%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
46.30
-7.20
-15.55%
Less: Accumulated Depreciation
22.88
16.12
6.76
41.94%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
30.17
-13.95
-46.24%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.90
-0.90
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
9.23
-7.11
-77.03%
Long Term Loans & Advances
6.64
1.92
4.72
245.83%
Other Non Current Assets
0.01
0.00
0.01
0.00%
Total Non-Current Assets
24.98
43.51
-18.53
-42.59%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
10.22
35.26
345.01%
Sundry Debtors
133.46
23.14
110.32
476.75%
Cash and Bank
1.47
0.36
1.11
308.33%
Other Current Assets
0.78
1.91
-1.13
-59.16%
Short Term Loans and Advances
84.41
34.65
49.76
143.61%
Total Current Assets
265.61
70.27
195.34
277.98%
Net Current Assets (Including Current Investments)
116.40
-11.03
127.43
1,155.30%
Total Current Assets Excluding Current Investments
265.61
70.27
195.34
277.98%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
113.78
176.81
155.40%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
34.86
54.11
-19.25
-35.58%
Book Value per share (adjusted)
46.90
20.88
26.02
124.62%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






